Ilene A Claudius1,2, Ashlee Jontz3, Michael Levine4,5, Frank LoVecchio5, Paul Dabrowski3, Rachael Kreisler5,6. 1. Department of Emergency Medicine, Harbor UCLA Medical Center, Torrance, CA, USA. 2. University of California, Los Angeles. 3. Department of Surgery, Division of Trauma Surgery, Banner University Medical Center, Phoenix, AZ, USA. 4. Department of Emergency Medicine, Division of Medical Toxicology, University of Southern California. 5. Department of Medical Toxicology, Banner University Medical Center, Phoenix, AZ, USA. 6. Midwestern University. College of Graduate Studies, Glendale, AZ, USA.
Abstract
Background: Both marijuana use and legalization are increasing, and the cognitive effects of marijuana may play a role in trauma. Our objective was to assess the proportion of patients with a urine drug screen who self-reported use in a population of trauma patients. Methods: Self-report of marijuana use in trauma patients was recorded for patients with a positive urine toxicology screen at a Level 1 trauma center in Arizona prior to (1/2011 to 4/13/2011) and following (4/14/2011 to 9/2014) legalization of marijuana for medical indications. Results: Among patients with a positive toxicology screen who were able to report to utilization, 52.5% patients with a positive UDS for marijuana overall reported use. In the pre-legalization group, 59.3% reported use, while in the post-legalization group, 51.4% reported use (p = .188). Conclusion: Only about half of trauma patients with a positive urine drug screen for marijuana reported use. Self-reporting among UDS-positive patients demonstrated no significant change with the legalization of marijuana for medical reasons.
Background: Both marijuana use and legalization are increasing, and the cognitive effects of marijuana may play a role in trauma. Our objective was to assess the proportion of patients with a urine drug screen who self-reported use in a population of trauma patients. Methods: Self-report of marijuana use in trauma patients was recorded for patients with a positive urine toxicology screen at a Level 1 trauma center in Arizona prior to (1/2011 to 4/13/2011) and following (4/14/2011 to 9/2014) legalization of marijuana for medical indications. Results: Among patients with a positive toxicology screen who were able to report to utilization, 52.5% patients with a positive UDS for marijuana overall reported use. In the pre-legalization group, 59.3% reported use, while in the post-legalization group, 51.4% reported use (p = .188). Conclusion: Only about half of trauma patients with a positive urine drug screen for marijuana reported use. Self-reporting among UDS-positive patients demonstrated no significant change with the legalization of marijuana for medical reasons.
Entities:
Keywords:
Marijuana; drug self-report; drug use; legalization; self-reporting
Authors: Nicole V Tolan; Tolumofe Terebo; Peter R Chai; Timothy B Erickson; Bryan D Hayes; Sacha N Uljon; Athena K Petrides; Christiana A Demetriou; Stacy E F Melanson Journal: Clin Toxicol (Phila) Date: 2021-12-22 Impact factor: 4.467
Authors: S L Mumford; K S Flannagan; J G Radoc; L A Sjaarda; J R Zolton; T D Metz; T C Plowden; N J Perkins; E A DeVilbiss; V C Andriessen; Purdue-Smithe A C; K Kim; S F Yisahak; J R Freeman; Z Alkhalaf; R M Silver; E F Schisterman Journal: Hum Reprod Date: 2021-04-20 Impact factor: 6.918